SCHEMBL11299246

SCHEMBL11299246

CCCCc1ccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 11/20 0.46
▸ HDAC6 Q9UBN7 10/20 0.46
▸ HDAC3 O15379 5/20 0.46
▸ HDAC2 Q92769 5/20 0.46
▸ NCOR2 Q9Y618 1/20 0.46
▸ PLK1 P53350 1/20 0.45
▸ HDAC8 Q9BY41 5/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ GALR3 O60755 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ TRPV1 Q8NER1 2/20 0.41
▸ HDAC4 P56524 3/20 0.40
▸ HDAC7 Q8WUI4 3/20 0.40
▸ HDAC10 Q969S8 3/20 0.40
▸ HDAC11 Q96DB2 3/20 0.40
▸ HDAC9 Q9UKV0 3/20 0.40
▸ HDAC5 Q9UQL6 3/20 0.40
▸ PSEN1 P49768 1/20 0.40
▸ PSEN2 P49810 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301754 0.81 PSEN1 (0.42) HDAC1HDAC6HDAC2HDAC8PSEN1
SCHEMBL11305647 0.81 HDAC6 (0.41) HDAC1HDAC6HDAC3HDAC8KDM4E
SCHEMBL11297375 0.80 HDAC8 (0.44) HDAC1HDAC6HDAC3HDAC2HDAC8
SCHEMBL11296107 0.79 HDAC8 (0.45) HDAC1HDAC6HDAC3HDAC8RAB9A
SCHEMBL11296049 0.79 HDAC6 (0.45) HDAC1HDAC6HDAC8KDM4ENPC1
SCHEMBL11303328 0.78 HDAC8 (0.37) HDAC1HDAC6HDAC8KDM4ERAB9A
SCHEMBL11296595 0.77 HDAC6 (0.42) HDAC1HDAC6HDAC3HDAC2HDAC8
SCHEMBL11304336 0.76 HDAC6 (0.42) HDAC1HDAC6HDAC3HDAC2HDAC8
SCHEMBL11297519 0.76 HDAC6 (0.43) HDAC1HDAC6HDAC8KDM4ENPC1
SCHEMBL6919330 0.76 PLK1 (0.74) HDAC1HDAC6HDAC3HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback